285 related articles for article (PubMed ID: 25202123)
1. MicroRNAs 206 and 21 cooperate to promote RAS-extracellular signal-regulated kinase signaling by suppressing the translation of RASA1 and SPRED1.
Sharma SB; Lin CC; Farrugia MK; McLaughlin SL; Ellis EJ; Brundage KM; Salkeni MA; Ruppert JM
Mol Cell Biol; 2014 Nov; 34(22):4143-64. PubMed ID: 25202123
[TBL] [Abstract][Full Text] [Related]
2. MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways.
Gong B; Liu WW; Nie WJ; Li DF; Xie ZJ; Liu C; Liu YH; Mei P; Li ZJ
World J Gastroenterol; 2015 Feb; 21(5):1488-97. PubMed ID: 25663768
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).
Sun D; Yu F; Ma Y; Zhao R; Chen X; Zhu J; Zhang CY; Chen J; Zhang J
J Biol Chem; 2013 Mar; 288(13):9508-18. PubMed ID: 23322774
[TBL] [Abstract][Full Text] [Related]
4. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
[TBL] [Abstract][Full Text] [Related]
6. Abnormal H3K27 histone methylation of RASA1 gene leads to unexplained recurrent spontaneous abortion by regulating Ras-MAPK pathway in trophoblast cells.
Zhang J; Liu X; Gao Y
Mol Biol Rep; 2021 Jun; 48(6):5109-5119. PubMed ID: 34173139
[TBL] [Abstract][Full Text] [Related]
7. Role of RASA1 in cancer: A review and update (Review).
Zhang Y; Li Y; Wang Q; Su B; Xu H; Sun Y; Sun P; Li R; Peng X; Cai J
Oncol Rep; 2020 Dec; 44(6):2386-2396. PubMed ID: 33125148
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1.
Kent OA; Mendell JT; Rottapel R
Mol Cancer Res; 2016 Mar; 14(3):267-77. PubMed ID: 26747707
[TBL] [Abstract][Full Text] [Related]
9. CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1.
Xiao W; Zheng S; Zou Y; Yang A; Xie X; Tang H; Xie X
Aging (Albany NY); 2019 Dec; 11(24):12043-12056. PubMed ID: 31857500
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
Liu X; Xu Y; Deng Y; Li H
Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
[TBL] [Abstract][Full Text] [Related]
11. Sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein (SPRED1), a tyrosine-protein phosphatase non-receptor type 11 (SHP2) substrate in the Ras/extracellular signal-regulated kinase (ERK) pathway.
Quintanar-Audelo M; Yusoff P; Sinniah S; Chandramouli S; Guy GR
J Biol Chem; 2011 Jul; 286(26):23102-12. PubMed ID: 21531714
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer.
Sharma SB; Ruppert JM
Drug Dev Res; 2015 Sep; 76(6):328-42. PubMed ID: 26284568
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑4530 suppresses cell proliferation and induces apoptosis by targeting RASA1 in human umbilical vein endothelial cells.
Jing L; Li H; Zhang T; Lu J; Zhong L
Mol Med Rep; 2019 May; 19(5):3393-3402. PubMed ID: 30864691
[TBL] [Abstract][Full Text] [Related]
14. Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells.
Lei H; Li H; Tian L; Li M; Xin Z; Zhang X; Guan R
Drug Des Devel Ther; 2018; 12():1743-1751. PubMed ID: 29942117
[TBL] [Abstract][Full Text] [Related]
15. miR182 activates the Ras-MEK-ERK pathway in human oral cavity squamous cell carcinoma by suppressing RASA1 and SPRED1.
Wang J; Wang W; Li J; Wu L; Song M; Meng Q
Onco Targets Ther; 2017; 10():667-679. PubMed ID: 28223824
[TBL] [Abstract][Full Text] [Related]
16. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells.
Liu P; Wilson MJ
J Cell Physiol; 2012 Feb; 227(2):867-76. PubMed ID: 21898400
[TBL] [Abstract][Full Text] [Related]
17. C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.
Sun D; Wang C; Long S; Ma Y; Guo Y; Huang Z; Chen X; Zhang C; Chen J; Zhang J
Br J Cancer; 2015 Apr; 112(9):1491-500. PubMed ID: 25867276
[TBL] [Abstract][Full Text] [Related]
18. The long noncoding RNA MEG3 regulates Ras-MAPK pathway through RASA1 in trophoblast and is associated with unexplained recurrent spontaneous abortion.
Zhang J; Liu X; Gao Y
Mol Med; 2021 Jul; 27(1):70. PubMed ID: 34238211
[TBL] [Abstract][Full Text] [Related]
19. SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling.
Siljamäki E; Abankwa D
Mol Cell Biol; 2016 Oct; 36(20):2612-25. PubMed ID: 27503857
[TBL] [Abstract][Full Text] [Related]
20. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
